No CrossRef data available.
Article contents
La levomepromacina ayuda a reducir los problemas de sueño en pacientes con trastorno por estrés postraumático
Published online by Cambridge University Press: 12 May 2020
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Keywords
- Type
- Caso clínico
- Information
- Copyright
- Copyright © European Psychiatric Association 2004
References
Bibliografía
Berlant, J, van Kammen, DROpen label Topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry 2002;63:15–20.CrossRefGoogle ScholarPubMed
Blake, DD, Weathers, FW, Nagy, LM, et al.The development of a Clinician Administered PTSD scale. J Trauma Stress 1995;8:75–80.CrossRefGoogle ScholarPubMed
Gillin, JC, Smith-Vaniz, A, Schnierow, B, Rapaport, MH, Kelsoe, J, Raimoe, E, et al.An open-label, 12-week clinical and EEG study of nafazo-done in chronic combat relatad posttraumatic stress disorder. J Clin Psychiatry 2001;62:789–96.CrossRefGoogle ScholarPubMed
Neylan, TC, Marmar, CR, Meltzer, TJ, et al.Sleep disturbances in the Vietnam generation findings from a nationally representative sample of male Vietnam veterans. Am J Psychiatry 1998;155:929–33.CrossRefGoogle ScholarPubMed
Raskind, MA, Thompson, C, Petrie, EC, Doble, DJ, Rein, RJ, Hoff, DJ, et al.Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry 2002;63:565–8.CrossRefGoogle ScholarPubMed
Rennemo, F, Larsen, R, Breivik, H. Avoiding psychic adverse effects during induction of neurolept anaesthesia with levomepromazine. A double-blind study of levomepromazine and droperidol. Acta Ana-esthesiol Scand 1982;26:108–11.CrossRefGoogle ScholarPubMed
Shiloh, R, Nutt, D, Weizman, A.Atlas of psychiatric pharmacotherapy. London: Martin Dunitz; 2000 [rev. ed.].Google Scholar